Literature DB >> 7566582

Imbalance between intraperitoneal coagulation and fibrinolysis during peritonitis of CAPD patients: the role of mesothelial cells.

T Sitter1, M Spannagl, H Schiffl, E Held, V W van Hinsbergh, T Kooistra.   

Abstract

We compared peritoneal dialysis effluents from 18 CAPD patients who had not suffered from peritonitis during the last 6 months (group 1) with the effluents from five patients with acute peritonitis (group 2), measuring activation markers of coagulation and fibrinolysis. These markers included prothrombin fragment F1 + 2 (F1 + 2), thrombin-antithrombin III complex (TAT), fibrin monomer (FM), and fibrin degradation products (FbDP). In the dialysate of group 1 we found remarkably high levels of F1 + 2, TAT and FM concomitant with a high concentration of FbDP, indicating a high rate of intraperitoneal fibrin turnover. The balance between peritoneal generation and degradation of fibrin was disturbed in untreated patients of group 2, who had significantly higher levels of coagulation markers and a higher ratio between FM and FbDP. Seven days after treatment with intraperitoneal administration of antibiotics and heparin, F1 + 2, TAT, FM and FbDP decreased significantly. To evaluate the role of mesothelial cells (MC) in the high peritoneal fibrin turnover we investigated the expression of tissue-type plasminogen activator (t-PA), urokinase-type plasminogen activator (u-PA), plasminogen activator inhibitor type-1 (PAI-1), and tissue factor in cultured human peritoneal MC under basal conditions and after exposure to tumour necrosis factor alpha (TNF alpha), interleukin-1 alpha (IL-1 alpha), or bacterial lipopolysaccharide (LPS). The exposure of MC to TNF alpha or to a lesser extent IL-1 alpha or LPS reduced their fibrinolytic activity by decreasing t-PA production and increasing PAI-1 synthesis.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7566582

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  8 in total

1.  Can effluent matrix metalloproteinase 2 and plasminogen activator inhibitor 1 be used as biomarkers of peritoneal membrane alterations in peritoneal dialysis patients?

Authors:  Deirisa Lopes Barreto; Annemieke M Coester; Dirk G Struijk; Raymond T Krediet
Journal:  Perit Dial Int       Date:  2013-09-01       Impact factor: 1.756

Review 2.  Peritoneal damage by peritoneal dialysis solutions.

Authors:  Takafumi Ito; Noriaki Yorioka
Journal:  Clin Exp Nephrol       Date:  2008-02-15       Impact factor: 2.801

Review 3.  Encapsulating peritoneal sclerosis in children.

Authors:  Constantinos J Stefanidis; Rukshana Shroff
Journal:  Pediatr Nephrol       Date:  2013-11-21       Impact factor: 3.714

4.  Impact of low-dose urokinase in peritoneal dialysis on serum oxidative stress, nitric oxide and endothelin in cerebral infarction complicated with uremia.

Authors:  Zhong-Sen Qu; Qing-De Zhang; Liang Li
Journal:  Int J Clin Exp Med       Date:  2015-01-15

5.  Extracellular Vesicles Derived from Adipose Mesenchymal Stem Cells Promote Peritoneal Healing by Activating MAPK-ERK1/2 and PI3K-Akt to Alleviate Postoperative Abdominal Adhesion.

Authors:  Manyu Shi; Hengchen Liu; Tingting Zhang; Mingzhao Zhang; Xin Tang; Zenan Zhang; Wenjun Lu; Shulong Yang; Zhitao Jiang; Qingbo Cui; Zhaozhu Li
Journal:  Stem Cells Int       Date:  2022-05-05       Impact factor: 5.131

6.  Comparison of intraperitoneal antithrombin III and heparin in experimental peritonitis.

Authors:  Sema Akman; Mustafa Koyun; Tekinalp Gelen; Mesut Coskun
Journal:  Pediatr Nephrol       Date:  2008-05-06       Impact factor: 3.714

7.  Recombinant GPI-anchored TIMP-1 stimulates growth and migration of peritoneal mesothelial cells.

Authors:  Roghieh Djafarzadeh; Matthias Sauter; Susan Notohamiprodjo; Elfriede Noessner; Pankaj Goyal; Wolfgang Siess; Markus Wörnle; Andrea Ribeiro; Susanne Himmelein; Thomas Sitter; Peter J Nelson
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

Review 8.  Pathophysiological changes to the peritoneal membrane during PD-related peritonitis: the role of mesothelial cells.

Authors:  Susan Yung; Tak Mao Chan
Journal:  Mediators Inflamm       Date:  2012-04-10       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.